| Literature DB >> 26412718 |
Alix E Hall1, Chris Paul2, Jamie Bryant3, Marita C Lynagh4, Philip Rowlings5, Anoop Enjeti6, Hannah Small7.
Abstract
To conduct a comprehensive review to examine among hematological cancer patients: (1) rates of adherence to self-administered cancer treatments; and (2) factors impacting on their adherence. Fifty two eligible publications were identified. The majority focused on Chronic Myeloid Leukaemia (CML) (n=40) and Acute Lymphoid Leukaemia (ALL) (n=11) patients. Adherence rates varied and depended on the definition and measures used. Patient understanding about their disease and treatment, and forgetting to take their medication impacted on patients' level of adherence; while the use of reminders reduced forgetfulness. There is a lack of valid and reliable information relating to medication adherence of hematological cancer patients. Based on the limited data available we provide a profile of CML and ALL patients at potential risk of medication non-adherence, as well as a proposed checklist that can be used by health care providers in assessing and supporting patients in adhering to their medication.Entities:
Keywords: Adherence; Compliance; Hemato-oncology; Hematological cancer; Medication
Mesh：
Substances：
Year: 2015 PMID： 26412718 DOI： 10.1016/j.critrevonc.2015.08.025
Source DB: PubMed Journal: Crit Rev Oncol Hematol ISSN： 1040-8428 Impact factor: 6.312